Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Marchex (MCHX) Gains from Sales and Divestitures (2016 - 2025)

Marchex (MCHX) has 16 years of Gains from Sales and Divestitures data on record, last reported at $273000.0 in Q4 2025.

  • On a quarterly basis, Gains from Sales and Divestitures fell 24.38% to $273000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $273000.0, a 24.38% decrease, with the full-year FY2025 number at $273000.0, down 24.38% from a year prior.
  • Gains from Sales and Divestitures reached $273000.0 in Q4 2025 per MCHX's latest filing, up from $270000.0 in the prior quarter.
  • Over the last five years, Gains from Sales and Divestitures for MCHX hit a ceiling of $535000.0 in Q4 2023 and a floor of $71.0 in Q1 2021.
  • A 5-year average of $166458.2 and a median of $105500.0 in 2024 define the central range for Gains from Sales and Divestitures.
  • Peak YoY movement for Gains from Sales and Divestitures: tumbled 49.05% in 2021, then surged 71072.96% in 2024.
  • Tracing MCHX's Gains from Sales and Divestitures over 5 years: stood at $476000.0 in 2021, then increased by 3.36% to $492000.0 in 2022, then grew by 8.74% to $535000.0 in 2023, then crashed by 32.52% to $361000.0 in 2024, then dropped by 24.38% to $273000.0 in 2025.
  • Business Quant data shows Gains from Sales and Divestitures for MCHX at $273000.0 in Q4 2025, $270000.0 in Q3 2025, and $233000.0 in Q2 2025.